"We will continue to review opportunities as they
Post# of 145345
![](/assets/46931549/no_avatar_available_thumb.jpg)
"and other opportunities the Company will be pursuing.." --- May 28, 2024
Now it's --- "Will be"
Can't forget also the non-dilutive intent.
Not to mention if an outstanding agreement is announced this week on the Colorectal trial --- no looking back.
Even without initial clinical results yet.
Shall see.....
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)